FDA Approved: ASCLERA — Supplemental Application (Methapharm, Inc)

View source ↗

Summary

FDA approved a supplemental application for ASCLERA (polidocanol) submitted by Methapharm, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Telangiectasia
• Varicose Veins

Drugs mentioned

• ASCLERA (Polidocanol)

Snippet

SUPPL AP for ASCLERA (POLIDOCANOL)